Bioactive Ingredients
BioIngr
Instituto de Investigación Sanitaria Biogipuzkoa
San Sebastián, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria Biogipuzkoa (1)
2018
-
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study
Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704